Sponsors should consider best practices for maintaining data generated during sample analysis and instrument maintenance.
Thomas Purdue
Advertisement
Thomas Purdue is quality analyst V, Boehringer Ingelheim.
Articles by Thomas Purdue
Maintaining a quality culture across the diverse functions in a bio/pharmaceutical company is difficult. Representatives of the Quality Coordinating Committee of IQ Consortium report on collaborative efforts to address data integrity and the modernization of FDA’s good laboratory practice regulations.
Advertisement
Latest Updated Articles
Data Integrity Considerations for Vendor-Generated Data Associated with Analytical TestingPublished: July 16th 2021 | Updated:
Collaborative Efforts Address Key Data Integrity ChallengesPublished: March 16th 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
5
